Didier Clenet

Biography

Didier Clenet started working in the R&D Department of Formulation and Stability Platform of Sanofi-Pasteur in 2011. His work focuses on high throughput screening formulations, stability prediction using advanced kinetics, vaccine activity - structure relationship, particulate matter in vaccines and adjuvants process optimization and physic-chemical characterization. For more than 15 years in Sanofi R&D, he has worked on physical and biophysical characterization of active ingredients, freeze-dried products and monoclonal antibodies. He has developed novel X-ray diffraction and thermal analysis tools to study polymorphism and amorphous state in solid materials. His research interests are structural characterization and aggregation state determination using a variety of biophysical techniques (light scattering, flow-imaging, DSC and thermo-kinetics, fluorescence and infra-red spectroscopy, etc.). Didier Clenet started working in the R&D Department of Formulation and Stability Platform of Sanofi-Pasteur in 2011. His work focuses on high throughput screening formulations, stability prediction using advanced kinetics, vaccine activity - structure relationship, particulate matter in vaccines and adjuvants process optimization and physic-chemical characterization. For more than 15 years in Sanofi R&D, he has worked on physical and biophysical characterization of active ingredients, freeze-dried products and monoclonal antibodies. He has developed novel X-ray diffraction and thermal analysis tools to study polymorphism and amorphous state in solid materials. His research interests are structural characterization and aggregation state determination using a variety of biophysical techniques (light scattering, flow-imaging, DSC and thermo-kinetics, fluorescence and infra-red spectroscopy, etc.).

Research Interest

Vaccines and Immunology